Manhattan Scientifics, Inc.
MHTX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 0% | 0% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | – | -5,412% | -7,222% | 8,682% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | – | -5,460% | -7,278% | 8,628% |
| EPS Diluted | -0.002 | -0.005 | -0.007 | 0.007 |
| % Growth | 57.1% | 24.6% | -189% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |